Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
03 01 2019
Historique:
received: 21 03 2018
revised: 14 06 2018
accepted: 16 06 2018
pubmed: 1 7 2018
medline: 7 6 2019
entrez: 1 7 2018
Statut: ppublish

Résumé

The Advisory Committee on Immunization Practices recommends Hepatitis B (HepB) vaccine for previously unvaccinated adults <60 years with diabetes mellitus. This observational retrospective cohort study assessed the impact of implementing electronic provider reminders on HepB vaccine initiation and 3-dose series completion rates among insured adults with diabetes aged 19-59 years old. Difference-in-difference (DID) analyses compared changes in vaccine initiation and completion rates (ratio of the rate ratio [RRR] and 95% confidence interval [CI]) during 12 months pre- and post-implementation between intervention and control sites. We examined trends in vaccine initiation and completion rates by plotting monthly rates during the study period. We also calculated the overall HepB vaccine coverage rates with 95% CI among all adults with diabetes aged 19-59 years old at the start and end date of the study period. Baseline HepB vaccine initiation and completion rates were similar at both the intervention and control sites. Gender, age, and race/ethnicity distributions within both sites were similar during the 12 months pre- and post-implementation. DID analyses demonstrated statistically significant differences in the changes of the annual vaccine initiation rates (RRR: 70.7, 95% CI: 62.8-79.6) and the third dose completion rates (RRR = 18.7, 95% CI: 14.2-24.8) between the two sites. The coverage increased significantly at the intervention site while it remained low at the control site. Use of provider reminders is highly effective in increasing both HepB vaccine initiation and series completion rates among adults with diabetes.

Identifiants

pubmed: 29958736
pii: S0264-410X(18)30863-6
doi: 10.1016/j.vaccine.2018.06.035
pii:
doi:

Substances chimiques

Hepatitis B Vaccines 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-201

Informations de copyright

Copyright © 2018 Rulin C. Hechter, Lei Qian, Yi Luo, Deborah S. Ling Grant, Roger Baxter, Nicola P. Klein, Karen Valdez Nunley, Laurie Aukes, Cosmina Hogea, Girishanthy Krishnarajah, Brandon J. Patterson, Theresa M. Im, Hung Fu Tseng. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Rulin C Hechter (RC)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: Rulin.C.Hechter@kp.org.

Lei Qian (L)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: Lei.X.Qian@kp.org.

Yi Luo (Y)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: Yi.X.Luo@kp.org.

Deborah S Ling Grant (DS)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: Deborah.S.Ling-Grant@kp.org.

Roger Baxter (R)

Kaiser Permanente Northern California, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA.

Nicola P Klein (NP)

Kaiser Permanente Northern California, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA. Electronic address: nicola.klein@kp.org.

Karen Valdez Nunley (K)

Kaiser Permanente Northern California, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA. Electronic address: Karen.V.Nunley@kp.org.

Laurie Aukes (L)

Kaiser Permanente Northern California, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA. Electronic address: Laurie.A.Aukes@kp.org.

Cosmina Hogea (C)

GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA. Electronic address: cosmina.s.hogea@gsk.com.

Girishanthy Krishnarajah (G)

GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA. Electronic address: shanthy.krishnarajah@cslbehring.com.

Brandon J Patterson (BJ)

GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA. Electronic address: brandon.j.patterson@gsk.com.

Theresa M Im (TM)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: theresa.m.im@kp.org.

Hung Fu Tseng (HF)

Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA 91101, USA. Electronic address: Hung-Fu.X.Tseng@kp.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH